MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for ...

ProMIS Neurosciences Inc. , a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, ...

Scientists at Northwestern University have developed a new approach that directly combats the progression of ...

Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...

If Apple makes enough progress, healthy people could receive the brain implant. Keyboards and mice will not be necessary to ...

Apple has partnered with Synchron, a neurotechnology startup that has developed the Stentrode, an implantable brain-computer ...

The treatment traps and neutralizes misfolded proteins to stop the progression of Alzheimer's disease and other neurodegenerative disorders.

Athira Pharma (ATHA) announced that the Company will present data from a Phase 1 clinical trial of ATH-1105 in healthy volunteers at the 4th Annual ALS drug Development Summit taking place from May 12 ...

Whether you splash yourself, nominate a friend, donate your time or assets, the point is to be open to others in need and not ...

Apple is reportedly collaborating with medtech startup Synchron to develop brain-computer interfaces, aiming to control ...